Synapse

← Pneumonia

Papers in Pneumonia

Page 3 · newest first

  1. Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groupsPneumonia · 2022
  2. The remarkable history of pneumococcal vaccination: an ongoing challengePneumonia · 2022
  3. Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patternsPneumonia · 2022
  4. Antibiotic prescription rationality and associated in-patient treatment outcomes in children under-five with severe pneumonia at Bwizibwera health center IV, Mbarara District, South-Western UgandaPneumonia · 2022
  5. Additional effect of azithromycin over β-lactam alone for severe community-acquired pneumonia-associated acute respiratory distress syndrome: a retrospective cohort studyPneumonia · 2022
  6. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic managementPneumonia · 2021
  7. Identified micro-organisms in hospitalized community-acquired pneumonia patients living near goat and poultry farmsPneumonia · 2021
  8. Candida species in community-acquired pneumonia in patients with chronic aspirationPneumonia · 2021
  9. Serotype distribution of invasive, non-invasive and carried Streptococcus pneumoniae in Malaysia: a meta-analysisPneumonia · 2021
  10. Association of nasopharyngeal viruses and pathogenic bacteria in children and their parents with and without HIVPneumonia · 2021
  11. The role of co-infections and secondary infections in patients with COVID-19Pneumonia · 2021
  12. Effect of prophylactic administration of antipyretics on the immune response to pneumococcal conjugate vaccines in children: a systematic reviewPneumonia · 2021
  13. Carriage of upper respiratory tract pathogens in rural communities of Sarawak, Malaysian BorneoPneumonia · 2021
  14. The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniaePneumonia · 2021
  15. HSV-pneumonitis in a patient with lung cancer receiving check point inhibitors – a case reportPneumonia · 2021
  16. Legionnaires’ disease in the time of COVID-19Pneumonia · 2021
  17. Determinants of community acquired pneumonia among 2 to 59 months of age children in Northeast Ethiopia: a case-control studyPneumonia · 2020
  18. An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New GuineaPneumonia · 2020
  19. E-cigarette, or vaping, product use-associated lung injury: a reviewPneumonia · 2020
  20. Etiology of community-acquired pneumonia in adults: a systematic reviewPneumonia · 2020
  21. Variation in clinical outcomes and process of care measures in community acquired pneumonia: a systematic reviewPneumonia · 2020
  22. Tuberculosis in migrants – screening, surveillance and ethicsPneumonia · 2020
  23. Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive populationPneumonia · 2020
  24. Prevalence of gram negative bacteria causing community acquired pneumonia among adults in Mwanza City, TanzaniaPneumonia · 2020
  25. Validation for using electronic health records to identify community acquired pneumonia hospitalization among people with and without HIVPneumonia · 2020
  26. Clinical characteristics and outcomes of patients with H1N1 influenza pneumonia admitted at a tertiary care hospital in Karachi, PakistanPneumonia · 2020
  27. Measuring accuracy of plethysmography based respiratory rate measurement using pulse oximeter at a tertiary hospital in IndiaPneumonia · 2020
  28. Promoting the use of social networks in pneumoniaPneumonia · 2020
  29. The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in EnglandPneumonia · 2019
  30. Meningococcal pneumonia: a reviewPneumonia · 2019
  31. Treatment of community-onset pneumonia in neutropenic cancer patients: β-lactam monotherapy versus combination antibiotic regimensPneumonia · 2019
  32. Risk factors associated with nasopharyngeal carriage and density of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children living in IndonesiaPneumonia · 2018
  33. Inter-hospital variation in the utilization of diagnostics and their proportionality in the management of adult community-acquired pneumoniaPneumonia · 2018
  34. Impact of the 23-valent pneumococcal polysaccharide vaccination in pregnancy against infant acute lower respiratory infections in the Northern Territory of AustraliaPneumonia · 2018
  35. Streptococcus pneumoniae outbreaks and implications for transmission and control: a systematic reviewPneumonia · 2018
  36. Corynebacteria as a cause of pulmonary infection: a case series and literature reviewPneumonia · 2018
  37. Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control studyPneumonia · 2018
  38. How low can we go? The implications of low bacterial load in respiratory microbiota studiesPneumonia · 2018
  39. Lung function in HIV-infected children and adolescentsPneumonia · 2018
  40. Anti-protein immunoglobulin M responses to pneumococcus are not associated with agingPneumonia · 2018
  41. Rapid molecular assays for detection of tuberculosisPneumonia · 2018
  42. Cilostazol for the prevention of pneumonia: a systematic reviewPneumonia · 2018
  43. The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational studyPneumonia · 2018
  44. Pneumococcal vaccination in older persons: where are we today?Pneumonia · 2018
  45. Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New GuineaPneumonia · 2017
  46. Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspectivePneumonia · 2017
  47. Risk factors for community-acquired pneumonia among adults in Kenya: a case–control studyPneumonia · 2017
  48. Community-acquired pneumonia in the United Kingdom: a call to actionPneumonia · 2017
  49. Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal populationAustralasian Journal of Paramedicine · 2017
  50. Pharmacologic inhibition of MEK1/2 reduces lung inflammation without impairing bacterial clearance in experimental Pseudomonas aeruginosa pneumoniaPneumonia · 2017